Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05522842
Other study ID # corneal endothelium
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date March 1, 2025

Study information

Verified date September 2022
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

evaluate and compare the changes in corneal endothelial cell count density between diabetic and non diabetic patients undergoing phacoemulsification surgery, and to evaluate the effect of duration, and control of diabetes on corneal morphology.


Description:

Diabetes mellitus (DM) is a major health hazard reaching epidemic proportions. Worldwide more than 285 million people are affected by DM; this number is expected to increase to 439 million by 2030 according to the international diabetes federation. DM affects every part of the body and the eye is not an exception. Diabetes mellitus has been found to be detrimental to corneal endothelium . Patients with diabetes have been found to have morphologically abnormal endothelium, including pleomorphism and polymegethism. Also, elderly patients with diabetes mellitus undergo phacoemulsification is particularly vulnerable to greater endothelial damage during surgery than non diabetics. Several studies showed that diabetes mellitus has a lower impact on corneal cell density and morphology in patients with good glycemic control , also patients with diabetes over 10 years have more corneal morphological abnormalities than those having diabetes under 10 years duration. Patients with DM tend to develop cataract more frequently and earlier than non diabetics. Corneal endothelium plays an important role in maintaining dehydrated state and transparency of cornea throughout life, by pumping excess fluid out of stroma through active transport mechanism and barrier function. Any compromise in these factors leads to direct effect on corneal endothelium . Cataract has been documented to be the most significant cause of bilateral blindness . Cataract extraction with phacoemulsification is one of the most common surgical procedure performed nowadays, with an estimated 19 million operation performed annually worldwide. The WHO states that this number will increase to 32 million by 2025, however corneal endothelium is known to undergo damage during phacoemulsification in many different ways, it may be injured mechanically as result of instrumentation causing postoperative complication such as corneal edema. Specular microscopy is used for non invasive viewing and recording of the image of corneal endothelial cell layer. Several studies have used specular microscopy for quantitative assessment of the corneal damage associated with phacoemulsification by measuring the degree of decrease in the corneal cell density.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date March 1, 2025
Est. primary completion date November 1, 2024
Accepts healthy volunteers
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria: - Age from 40 to 70 - Any degree of cataract - No previous ocular surgery Exclusion Criteria: - Any corneal pathology, infection, or active inflammation - pseudoexofoliation - History of ocular trauma or surgery

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary corneal endothelium cell count normal range of 1500 to 3500 cells/mm2 (age, 40-90) baseline
Primary corneal endothelial cell size their dimension being roughly 50-70 µm long, 10-30 µm wide and 0.1-10 µm thick baseline
Primary corneal endothelial cell shape a single layer of cells organized in a characteristic honeycomb pattern baseline
See also
  Status Clinical Trial Phase
Completed NCT02470793 - Technique And Results In Endothelial Keratoplasty N/A
Completed NCT02276638 - Comparative Study of Specular Microscopes for Measurements of Cell Density, Coefficient of Variation and Hexagonality
Recruiting NCT04072978 - Anterior Chamber Versus Scleral Fixated Intraocular Lens: Long-term Vision and Safety Outcomes
Completed NCT03107000 - Corneal Endothelial Cell Loss After Trabeculectomy Versus Phakotrabeculectomy N/A
Completed NCT02128113 - RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD Phase 2
Completed NCT05447130 - Corneal Endothelium After Phacoemulsification in Pseudo Exfoliation Syndrome N/A
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Completed NCT06396156 - Anterior Versus Posterior Artisan Intraocular Lens Fixation in Aphakic Children With Insufficient Capsular Support. N/A
Withdrawn NCT03361709 - Effect of Intracameral Dexamethasone After Phacoemulsification in Diabetics on Corneal Endothelial Cell Density Phase 4
Completed NCT02427256 - Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed NCT02138266 - Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements
Completed NCT04396301 - Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco Phase 3
Recruiting NCT05847387 - The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study
Recruiting NCT05119270 - Comparison of Phacoemulsification and Corneal Damage Between FLACS and Standard Phaco With Two Handpieces N/A
Recruiting NCT01726790 - Effect of Intravitreal Bevacizumab on Corneal Endothelium N/A